BIO-FD&C Co.,Ltd.

KOSDAQ:A251120 Stock Report

Market Cap: ₩117.7b

BIO-FD&CLtd Balance Sheet Health

Financial Health criteria checks 6/6

BIO-FD&CLtd has a total shareholder equity of ₩61.4B and total debt of ₩1.2B, which brings its debt-to-equity ratio to 2%. Its total assets and total liabilities are ₩65.6B and ₩4.2B respectively. BIO-FD&CLtd's EBIT is ₩4.8B making its interest coverage ratio -4. It has cash and short-term investments of ₩44.0B.

Key information

2.0%

Debt to equity ratio

₩1.20b

Debt

Interest coverage ratio-4x
Cash₩44.01b
Equity₩61.38b
Total liabilities₩4.18b
Total assets₩65.56b

Recent financial health updates

No updates

Recent updates

We Think That There Are Some Issues For BIO-FD&CLtd (KOSDAQ:251120) Beyond Its Promising Earnings

Nov 19
We Think That There Are Some Issues For BIO-FD&CLtd (KOSDAQ:251120) Beyond Its Promising Earnings

Some Shareholders Feeling Restless Over BIO-FD&C Co.,Ltd.'s (KOSDAQ:251120) P/E Ratio

Oct 14
Some Shareholders Feeling Restless Over BIO-FD&C Co.,Ltd.'s (KOSDAQ:251120) P/E Ratio

A Look At The Fair Value Of BIO-FD&C Co.,Ltd. (KOSDAQ:251120)

Aug 06
A Look At The Fair Value Of BIO-FD&C Co.,Ltd. (KOSDAQ:251120)

Financial Position Analysis

Short Term Liabilities: A251120's short term assets (₩48.9B) exceed its short term liabilities (₩4.0B).

Long Term Liabilities: A251120's short term assets (₩48.9B) exceed its long term liabilities (₩202.5M).


Debt to Equity History and Analysis

Debt Level: A251120 has more cash than its total debt.

Reducing Debt: A251120's debt to equity ratio has reduced from 35.1% to 2% over the past 5 years.

Debt Coverage: A251120's debt is well covered by operating cash flow (534.8%).

Interest Coverage: A251120 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies